openPR Logo
Press release

Global Migraine Therapeutics Market Offers a Competitive Advantage till Forecast Period 2023

01-08-2019 12:12 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Reports World

Global Migraine Therapeutics Market Offers a Competitive

Migraine Therapeutics Market Report Coverage Highlights: This report covers drivers, restraints, opportunities, challenges, and market trends. The report also covers the product portfolio analysis of the Migraine Therapeutics products and vendor benchmarking of the top players in this market. In addition, this report highlights the growth strategies adopted by the major market players to garner large shares in the Migraine Therapeutics market.

The Global Migraine Therapeutics Market is expected to grow, at a CAGR of 8.4% over the forecast period, 2018-2023. Migraine is a complex neurological condition, characterized by frequent headaches that can last between four and 72 hours. The pain is often unilateral and pulsating in nature, which can often be worsened by physical activity. In most cases, migraine is associated with symptoms such as photophobia, phonophobia, osmophobia, nausea, vomiting, loss of appetite, and sometimes sensory disturbances.

A separate section with Migraine Therapeutics industry key players is included in the report, which provides a comprehensive analysis of price, cost, gross, revenue, product picture, specifications, company profile, and contact information. Development and Research plays a vital role towards the innovation in any given industry which require to execute. Additionally, performing research and development offers a competitive advantage over the competitors owing to regular introduction of products and prototypes to attract consumers. This is expected to have a positive impact on the Migraine Therapeutics market growth over the forecast period.

Request a Sample of this report from:

https://www.marketreportsworld.com/enquiry/request-sample/12347860   

Increasing prevalence of migraines

Migraine is a neurological disorder which can show incapacitating neurological symptoms. Migraine has been considered as the 3rd most prevalent disorder and 6th most disabling illness worldwide (according to the migraine trust). Migraine affects 18% of women and 6% of men in US. Migraine is mostly common in ages of 25 to 55. More than 4 million adults experience chronic daily migraine and it is estimated that approximately 1 out of 4 U.S. households has at least 1 person with migraine. 
Due to the high unmet needs the major pharmaceutical companies have initiated several R&D programs to launch new molecules and are trying to increase the market access of the generic formulations across the globe. Moreover, the growing awareness of migraine therapeutics and improvement in accurate diagnosis of the condition are expected to favor the market expansion over the next few years.

Lack of Proper Diagnosis and Undiagnosed Cases

About 37 million people in US suffer from migraine, however, the numbers can be much higher owing to the number of undiagnosed silent migraines. A silent migraine is a type of migraine that does not have headache as one of its characteristic symptoms. Symptoms for a silent migraine revolve around the type of a migraine that it is, as in case of vestibular migraine particularly affects the vestibular system which controls balance. Which results in the primary symptoms to be may be dizziness, vertigo, nausea, and vomiting. In this case there is a lack of a headache. These patients who bypass proper diagnosis would otherwise have been potential users of migraine therapeutics. This will lead to the slowdown of the growth of this market along with other factors such as adverse effects of drugs, increased preference for alternative therapies and generic penetration.

Asia-Pacific to Emerge as the Fastest Growing Region

APAC is quickly emerging as the fastest-growing region in the migraine drugs market and is expected to grow at approximately a CAGR of about 6% during the forecast period. The primary reason for this region’s growth is the increasing the number of migraine cases and growing public awareness about the disease. India and China are the major markets in this region as the prevalence of migraine is high in these countries. The growing focus on new product launches and the high penetration of drug manufacturers will aid in the growth of the market in APAC during the forecast period.

Key Developments in the Market:

March 2018 - A new type of medication for migraine headaches is currently being reviewed by the FDA, and if approved may provide safe, long-lasting relief for many by blocking the activation of a molecule involved in the pain process.

Major Players: ALLERGAN, AMIRALL, ASTRAZENECA, GLAXOSMITHKLINE, MERCK, OPTINOSE, PFIZER, REDHILL BIOPHARMA, REVANCE THERAPEUTICS, AND TEVA, amongst others.

Reasons to Purchase the Report

Current and future migraine therapeutics market outlook in the developed and emerging markets
Analysis of various perspectives of the market with the help of Porter’s five forces analysis
The segment that is expected to dominate the market
Regions that are expected to witness the fastest growth during the forecast period
Identify the latest developments, market shares, and strategies employed by the major market players
3 months analyst support, along with the Market Estimate sheet (in Excel)

Browse Full Report at: -

https://www.marketreportsworld.com/12347860

Customization of the Report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.     

Migraine Therapeutics Market Forecast 2018-2023

The Migraine Therapeutics industry research report analyses the supply, sales, production, and market status comprehensively. Production market shares and sales market shares are analysed along with the study of capacity, production, sales, and revenue. Several other factors such as import, export, gross margin, price, cost, and consumption are also analysed under the section Analysis of Migraine Therapeutics production, supply, sales and market status.

Lastly, this report covers the market landscape and its growth prospects over the coming years, the Report also brief deals with the product life cycle, comparing it to the relevant products from across industries that had already been commercialized details the potential for various applications, discussing about recent product innovations and gives an overview on potential regional market shares.

Detailed TOC of Global Migraine Therapeutics Market Forecasts (2018 - 2023)

Introduction
   1.1 Definition of the Market

   1.2 Key Findings of the Study

Research Scope and Methodology
   2.1 Study Deliverables

   2.2 Study Assumptions

   2.3 Research Methodology

   2.4 Research Phases

Market Dynamics
   3.1 Drivers

   3.1.1 Increasing Demand for Migraine Therapeutics

   3.1.2 Evolving R&D Priorities

   3.1.3 Adoption of Migraine Therapeutics

   3.2 Restraints

   3.2.1 Migraine Therapeutics Industry

   3.2.2 Migraine Therapeutics Types and Application

Industry Analysis
    4.1 Porter's Five Forces Analysis

    4.1.1 Bargaining Power of Suppliers

    4.1.2 Bargaining Power of Buyers

    4.1.3 Threats of New Entrants

    4.1.4 Threats of Substitute Products and Services

    4.1.5 Degree of Competition

Market Segmentation
  5.1 By Application

  5.2 By Geography

  5.2.1 North America

  5.2.1.1 US

  5.2.1.2 Canada

  5.2.1.3 Mexico

  5.2.1.4 Others

  5.2.2 Europe

  5.2.2.1 Spain

  5.2.2.2 UK

  5.2.2.3 France

  5.2.2.4 Germany

  5.2.2.5 Russia

  5.2.2.6 Italy

  5.2.2.7 Others

  5.2.3 Asia-Pacific

  5.2.3.1 China

  5.2.3.2 Japan

  5.2.3.3 India

  5.2.3.4 Australia

  5.2.3.5 Others

  5.2.4 South America

  5.2.4.1 Brazil

  5.2.4.2 Argentina

  5.2.4.3 Others

  5.2.5 Africa

  5.2.5.1 South Africa

  5.2.5.2 Others

Competitor Analysis
  6.1 Market Shares of Leading Players

  6.2 Strategies Adopted by Leading Players

Company Profiles
Future Outlook of the Market
Appendix
Price of Report (single User Licence): $4250

Purchase the Migraine Therapeutics Market Report at: 

https://www.marketreportsworld.com/purchase/12347860

Market is changing rapidly with the ongoing expansion of the industry. Advancement in the technology has provided today’s businesses with multifaceted advantages resulting in daily economic shifts. Thus, it is very important for a company to comprehend the patterns of the market movements in order to strategize better. An efficient strategy offers the companies with a head start in planning and an edge over the competitors. Market Reports World is the credible source for gaining the market reports that will provide you with the lead your business needs.

Market Reports World

3rd Floor, Silver Spring, Sahyadri farms,

Opp Prabhavee Tech Park,

Baner - Mhalunge Road, Baner, Pune 411045.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Migraine Therapeutics Market Offers a Competitive Advantage till Forecast Period 2023 here

News-ID: 1479134 • Views:

More Releases from Market Reports World

Employee Wellness Software Market - Industry Forecast (2023 - 2030)
Employee Wellness Software Market - Industry Forecast (2023 - 2030)
Pre and Post-Covid Report Is Covered | Final Report Will Add the Analysis of the Impact of Russia-Ukraine War and COVID-19 on This Industry. Global "Employee Wellness Software Market" Research Report 2023 is spread across 104 pages and provides Size, Share, Growth, and Forecast with exclusive vital statistics, data, information, trends, and competitive landscape details in this niche sector. Get a sample PDF of the report -https://www.marketreportsworld.com/enquiry/request-sample/23544729 Employee Wellness Software Market research report
Global Cognitive Analytics Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, And Growth Forecast to 2030
Global Cognitive Analytics Market Analysis, Drivers, Restraints, Opportunities, …
Pre and Post-Covid Report Is Covered | Final Report Will Add the Analysis of the Impact of Russia-Ukraine War and COVID-19 on This Industry. Global "Cognitive Analytics Market" Research Report 2023 is spread across 101 pages and provides Size, Share, Growth, and Forecast with exclusive vital statistics, data, information, trends, and competitive landscape details in this niche sector. Get a sample PDF of the report -https://www.marketreportsworld.com/enquiry/request-sample/23545001 Cognitive Analytics Market research report offers New
Adventure and Safari Market Report Presents Latest Development Process and Key Growth Factors 2030
Adventure and Safari Market Report Presents Latest Development Process and Key G …
Pre and Post-Covid Report Is Covered | Final Report Will Add the Analysis of the Impact of Russia-Ukraine War and COVID-19 on This Industry. Global "Adventure and Safari Market" Research Report 2023 is spread across 120 pages and provides Size, Share, Growth, and Forecast with exclusive vital statistics, data, information, trends, and competitive landscape details in this niche sector. Get a sample PDF of the report -https://www.marketreportsworld.com/enquiry/request-sample/23545009 Adventure and Safari Market research report
Cardiac Cath Lab Market Report Explain the Distribution Process of Market forecast 2023-2030
Cardiac Cath Lab Market Report Explain the Distribution Process of Market foreca …
Pre and Post-Covid Report Is Covered | Final Report Will Add the Analysis of the Impact of Russia-Ukraine War and COVID-19 on This Industry. Global "Cardiac Cath Lab Market" Research Report 2023 is spread across 107 pages and provides Size, Share, Growth, and Forecast with exclusive vital statistics, data, information, trends, and competitive landscape details in this niche sector. Get a sample PDF of the report -https://www.marketreportsworld.com/enquiry/request-sample/23545162 Cardiac Cath Lab Market research report

All 5 Releases


More Releases for Migraine

Leading Growth Driver in the Migraine Market Share in 2025: Rising Prevalence Of …
What Market Share dynamics are playing a key role in accelerating the growth of the migraine Market Share? The migraine Market Share is projected to grow, driven by the rising occurrence of migraines. Migraines, a kind of headache that typically affects one side of the brain and causes intense, throbbing pain or a pulsing sensation, can be managed and relief can be provided via proper treatment. This treatment paves the way
Emerging Acute Migraine Treatment Market Trend 2025-2034: Innovative CGRP Recept …
How Is the Acute Migraine Treatment Market Projected to Grow, and What Is Its Market Size? The market size for acute migraine treatment has witnessed substantial growth in the past few years. Forecasts expect it to expand from $2.6 billion in 2024 to $2.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the historical period include the rising incidence of migraines,
Key Influencer in the Migraine Market 2025: Rising Prevalence Of Migraine Drives …
"What Is the Forecasted Market Size and Growth Rate for the Migraine Market? The migraine market is projected to grow steadily from $1.93 billion in 2024 to $1.97 billion in 2025, at a CAGR of 2.2%. This growth is attributed to the rising prevalence of migraines, growing awareness of treatment options, government initiatives, increased alcohol consumption, and lifestyle changes. Migraine Market: Expected to grow to $2.25 billion by 2029 at a CAGR
How Big is Migraine Drugs Market?
In 2022, the Global Migraine Drugs Market soared to USD 10,972.1 million, marking a significant milestone. Projections indicate a promising trajectory, with expectations set for substantial growth, potentially reaching USD 26,618.96 million by 2031. Forecasts for the period between 2024 and 2031 suggest a robust Compound Annual Growth Rate (CAGR) of 12.1% for the migraine drugs market. The objectives outlined in the report are multifaceted and aimed at offering a comprehensive
Migraine Therapeutics Market - Relieve the Burden: Empowering Lives through Migr …
Newark, New Castle, USA - new report, titled Migraine Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Migraine Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Migraine Therapeutics market. The report offers an overview of the market, which
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases. The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs. Get Access to TOC /